Immunopharmacological treatment in myasthenia gravis.
Nyberg-Hansen
R
R
Department of Neurology, Rikshospitalet, University of Oslo, Norway.
Gjerstad
L
L
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000628:therapy; D001379:Azathioprine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000628:therapy; D010951:Plasma Exchange; D011950:Receptors, Cholinergic / Q000276:immunology; D013934:Thymectomy
D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D003524:Cyclosporins; D011950:Receptors, Cholinergic; D001379:Azathioprine